CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vaishali Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vaishali Pharma Ltd
706-709, Aravalli Business Center R.C.Pa
tel Road, Sodawala Lane, Borivili (West)
Phone: +91 2242171819p:+91 2242171819 MUMBAI, 400092  India Ticker: VAISHALIVAISHALI

Business Summary
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is into the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. It has its global presence across Asia & Pacific, Africa, Commonwealth of Independent States, America, and the Middle East.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20243/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Managing Director AtulVasani 52 3/25/2017 3/25/2017
Chief Executive Officer Hemanth D.Pathak 5/26/2020 5/26/2020
Chief Financial Officer RatneshSingh 39 5/25/2017 5/25/2017
7 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 130,462,130 (As of 10/17/2024)
Shareholders: 9,508
Stock Exchange: NSE
Fax Number: +91 2228928833


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024